Trending Now
LATEST ARTICLES
The First Prescription Digital Therapeutic for Anxiety & Depression
Happify Health launched Ensemble, the first and only transdiagnostic prescription digital therapeutic for the treatment of patients who have Major Depressive Disorder (MDD) or...
AI Partnerships Are Reshaping Pharma: What Marketers Need to Know About the New Power...
What happens when pharmaceutical companies no longer just use technology but depend on it to make decisions? That question sits at the center of...
The Portfolio Fragmentation Challenge: How Marketers Can Maintain a Clear Story Amid Constant Acquisitions
What happens when your brand story changes every quarter? For many pharma marketers, that question feels less theoretical and more like a daily reality....
Speed vs Safety: How Pharma Marketers Can Compete in a Faster, More Scrutinized Market
Speed in pharma marketing is no longer just a competitive advantage. It is quickly becoming a necessity. As approvals accelerate and digital channels evolve,...
The Demand–Evidence Gap: What GLP-1 Growth Teaches Pharma Marketers About Responsible Messaging
The rise of GLP-1 therapies has reshaped how people think about chronic disease treatment, but it also highlights a growing tension between pharma demand...
The Algorithmic Gatekeeper: How Pharma Marketers Can Stay Visible in AI-Filtered Channels
AI-driven content optimization in pharma is no longer optional. Today, algorithms decide what healthcare professionals and patients actually see. Think about it like a...
When AI Speaks for Your Brand: What Pharma Marketers Must Do to Stay in...
The risk of AI in pharma compliance is no longer a distant concern. It is happening right now as artificial intelligence tools generate drug-related...
From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point of View
Why do some pharmaceutical brands stick in your mind while others fade almost instantly? It is rarely about who has the most data or...
The Velocity Problem: When Pharma Marketing Moves Slower Than the Market
Speed in pharma marketing has become a defining factor in success, yet many organizations still move at a pace that no longer matches today’s...
Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk
Most pharma audience strategies have traditionally focused on healthcare professionals and patients, but is that still enough in today’s complex landscape? Increasingly, unseen stakeholders...
The Trust Ceiling: Why Some Pharma Brands Can’t Improve Perception—No Matter the Spend
Have you ever wondered why some pharmaceutical brands keep increasing their budgets, yet public perception barely improves? This paradox sits at the heart of...
